Stokes Healthcare Inc., dba Epicur Pharma
FDA 503B outsourcing facility
Mt. Laurel, New Jersey
Key Takeaways
- FDA-registered 503B outsourcing facility since 2018
- Sterile compounding from bulk substances: Yes
- Last FDA inspection: May 23, 2025
About this facility
A 503B outsourcing facility is registered with the FDA under the Drug Quality and Security Act and may compound sterile medications in bulk without patient-specific prescriptions, under cGMP manufacturing standards. How federal compounding status works.
FDA registration and inspection record
- First registered with FDA
- January 30, 2018
- Most recent registration
- November 19, 2025
- Compounds sterile drugs from bulk substances
- Yes
- Last FDA inspection
- May 23, 2025
The FDA last inspected Stokes Healthcare Inc., dba Epicur Pharma on May 23, 2025. Investigators issued a Form FDA 483 listing inspectional observations at that visit. The FDA has not yet determined whether further action will be taken.
Compounded peptides and GLP-1s
Stokes Healthcare Inc., dba Epicur Pharma has not assigned NDCs or filed product reports in the most recent FDA reporting periods. 503B outsourcing facilities are a primary supply route for compounded peptides and GLP-1s during FDA-listed shortages; PeptideGrids grades the evidence for each, including Semaglutide, Tirzepatide, BPC-157, Retatrutide. Browse the GLP-1 and therapeutic peptide databases.
Location
6000 Commerce Pkwy, Mount Laurel, NJ 08054
Satellite and street imagery via Esri. Open larger map.
Contact
FDA-registered contact: Michael Tursi, 888-508-5032. Source: the facility's FDA outsourcing registration.
License verification
503B outsourcing facilities are also licensed by the state board of pharmacy. Verify the current license status of Stokes Healthcare Inc., dba Epicur Pharma with the New Jersey Board of Pharmacy.
503B facilities in New Jersey
New Jersey has 10 FDA-registered 503B outsourcing facilities in the PeptideGrids directory. See all 503B facilities in New Jersey.
Frequently asked questions
Is Stokes Healthcare Inc., dba Epicur Pharma registered with the FDA?
Yes. Stokes Healthcare Inc., dba Epicur Pharma is a registered 503B outsourcing facility, first registered with the FDA on January 30, 2018 and most recently registered on November 19, 2025.
Has Stokes Healthcare Inc., dba Epicur Pharma been inspected by the FDA?
The FDA last inspected Stokes Healthcare Inc., dba Epicur Pharma on May 23, 2025. A Form FDA 483 was issued.
Has Stokes Healthcare Inc., dba Epicur Pharma had any FDA drug recalls?
No FDA drug recalls are matched to Stokes Healthcare Inc., dba Epicur Pharma in the openFDA enforcement database.
What does Stokes Healthcare Inc., dba Epicur Pharma compound?
Stokes Healthcare Inc., dba Epicur Pharma has not filed product reports with NDC-assigned drugs in the most recent FDA reporting periods.
Where is Stokes Healthcare Inc., dba Epicur Pharma located?
Stokes Healthcare Inc., dba Epicur Pharma is located in Mt. Laurel, New Jersey (6000 Commerce Pkwy).
Registration and inspection data verified against the FDA list of registered outsourcing facilities on June 6, 2026.
PeptideGrids is independent and not affiliated with, endorsed by, or sponsored by Stokes Healthcare Inc., dba Epicur Pharma. Listings, registration, inspection, and recall data are reported from public FDA records for informational purposes only. A recall or inspection finding is not an accusation of current wrongdoing. This is not medical or legal advice. To request a correction, see our corrections policy.